Literature DB >> 9018429

Human vitreous hyaluronidase: isolation and characterization.

D M Schwartz1, S Shuster, M D Jumper, A Chang, R Stern.   

Abstract

PURPOSE: Hyaluronic acid (HA) is the predominant glycosaminoglycan (GAG) of the human vitreous. Interaction of this HA with vitreous collagen is important for maintaining gel structure. The mechanism of HA homeostasis in the vitreous is incompletely understood. The aim of this study was to determine whether hyaluronidase, an endoglycosidase that degrades HA, was present in human vitreous.
METHODS: Vitreous samples were collected from post-mortem eye bank specimens and from non-hemorrhagic, non-inflamed biopsy specimens. Vitreous hyaluronidase was purified by a series of column chromatographic steps, and its activity was measured by an ELISA-like assay and by substrate gel electrophoresis through and HA-impregnated gel. The purified hyaluronidase was also analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and by Western blotting.
RESULTS: Hyaluronidase activity was detected in vitreous samples from both post-mortem and biopsy specimens. The enzyme was most active at acid pH, but demonstrated significant activity at neutral pH. The partially purified enzyme migrated as a 59 kDa protein on SDS-PAGE, and a single band on Western blots.
CONCLUSIONS: Hyaluronidase is present in the human vitreous. Thus, hyaluronidase may be involved in HA catabolism in the vitreous and may play a role in determining its gel structure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9018429     DOI: 10.3109/02713689608995150

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

Review 1.  Clinical Applications of Hyaluronidase.

Authors:  Gregor Cornelius Weber; Bettina Alexandra Buhren; Holger Schrumpf; Johannes Wohlrab; Peter Arne Gerber
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

2.  Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo Study.

Authors:  Yu Yu; Laurence Chi Ming Lau; Amy Cheuk-Yin Lo; Ying Chau
Journal:  Transl Vis Sci Technol       Date:  2015-03-10       Impact factor: 3.283

3.  Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids.

Authors:  Rohit Bisht; Ilva D Rupenthal; Sreevalsan Sreebhavan; Jagdish K Jaiswal
Journal:  J Pharm Anal       Date:  2017-06-23

4.  A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.

Authors:  Pierre C Dromel; Deepti Singh; Eliot Andres; Molly Likes; Motoichi Kurisawa; Alfredo Alexander-Katz; Myron Spector; Michael Young
Journal:  NPJ Regen Med       Date:  2021-12-20

5.  Deciphering the Molecular Signature of Human Hyalocytes in Relation to Other Innate Immune Cell Populations.

Authors:  Julian Wolf; Stefaniya Boneva; Dennis-Dominik Rosmus; Hansjürgen Agostini; Günther Schlunck; Peter Wieghofer; Anja Schlecht; Clemens Lange
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

6.  Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.

Authors:  Soohyun Kim; Jennifer J Kang-Mieler; Wenqiang Liu; Zhe Wang; Glenn Yiu; Leandro B C Teixeira; William F Mieler; Sara M Thomasy
Journal:  Transl Vis Sci Technol       Date:  2020-02-27       Impact factor: 3.283

7.  Transcriptional Profiling Uncovers Human Hyalocytes as a Unique Innate Immune Cell Population.

Authors:  Stefaniya Konstantinova Boneva; Julian Wolf; Dennis-Dominik Rosmus; Anja Schlecht; Gabriele Prinz; Yannik Laich; Myriam Boeck; Peipei Zhang; Ingo Hilgendorf; Andreas Stahl; Thomas Reinhard; James Bainbridge; Günther Schlunck; Hansjürgen Agostini; Peter Wieghofer; Clemens A K Lange
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

8.  A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma.

Authors:  Lingxiao Xie; Weizhou Yue; Khaled Ibrahim; Jie Shen
Journal:  Pharmaceutics       Date:  2021-08-25       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.